Healthcare ❯Pharmaceuticals ❯Diabetes Treatment

GLP-1 Receptor Agonists

Novo Nordisk Products Mounjaro and Zepbound

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition